15289-s-bos

4 61 | Rebuttal AoVC in FH 23. Neefjes LA, Ten Kate GJ, Rossi A et al. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia. Heart 2011;97:1151-7. 24. Smith JG, Luk K, Schulz CA et al. Association of Low-Density Lipoprotein Cholesterol-Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis. Jama 2014. 25. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-53. 26. Rajamannan NM. Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology. Am J Physiol Heart Circ Physiol 2010;298:H5-15. 27. Messika-Zeitoun D, Bielak LF, Peyser PA et al. Aortic valve calcification: determinants and progression in the population. Arteriosclerosis, thrombosis, and vascular biology 2007;27:642-8. 28. Rossebo AB, Pedersen TR, Boman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-56. 29. Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97. 30. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, Investigators A. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14. 31. Rajamannan NM. Atorvastatin Attenuates Bone Loss and Aortic Valve Atheroma in LDLR Mice. Cardiology 2015;132:11-15. 32. Mohler ER, 3rd, Chawla MK, Chang AW et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. The Journal of heart valve disease 1999;8:254-60. 33. Mohler ER, 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8. 34. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology 2002;224:236-41. 35. Versmissen J, Oosterveer DM, Yazdanpanah M et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Bmj 2008;337:a2423. 36. Cosmi JE, Kort S, Tunick PA et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med 2002;162:2345-7. 37. McBride KL, Zender GA, Fitzgerald-Butt SM et al. Linkage analysis of left ventricular outflow tract malformations (aortic valve stenosis, coarctation of the aorta, and hypoplastic left heart syndrome). Eur J Hum Genet 2009;17:811-9. 38. Garg V, Muth AN, Ransom JF et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270- 4. 39. Nozue T, Fukui K, Yamamoto S et al. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology. Coronary artery disease 2013;24:481-6. 40. Nakazato R, Gransar H, Berman DS et al. Statins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry. Atherosclerosis 2012;225:148-53.